# Evolent Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/evolent-health

- Industry: Healthcare IT
- Headquarters: Arlington, US
- Website: www.evolent.com/
- Total disclosed funding: $100M
- Latest round: Series B (Sep 30, 2013)
- Investors on record: 3

## About

Evolent Health, LLC offers innovative healthcare solutions focused on enhancing patient care outcomes and operational efficiency for health plans across the United States and internationally.Evolent Health, LLC was founded in 2011 in Arlington, US, specializing in healthcare solutions. The company went public in June 2015, completing an IPO valued at USD 195 mn. The founders include Seth Blackley, who has a history of founding other ventures, along with CEOs Asit Gosar and Frank Williams. Evolent has completed a total of 3 deals, and as of the latest funding round, it has raised a total of USD 195 mn.Evolent specializes in providing a comprehensive suite of healthcare solutions aimed at improving patient care outcomes and operational efficiency for health plans. Their core offerings include clinical pathways, decision support tools, and an integrated digital platform that enhances patient and provider engagement, particularly in oncology, cardiology, musculoskeletal care, and primary care. Evolent's solutions are designed to facilitate high-quality treatment pathways, optimize pain management and surgical procedures, and ensure adherence to the latest clinical guidelines. The company serves a diverse client base, including health plans and independent providers, with a focus on markets across the United States, India, and the Philippines.In 2020, Evolent Health generated revenue of USD 1,022.43 mn, while reporting an EBITDA of USD -173.17 mn. The company's revenue model is based on partnerships with health plans and providers, utilizing subscription-based agreements for ongoing support and access to clinical pathways.Following its IPO in June 2015, where Evolent Health raised USD 195 mn, the company is focusing on expanding its product offerings and entering new markets. They are developing additional healthcare solutions to enhance their service capabilities, aiming for a rollout in the next few years. Evolent Health plans to target expansion into more geographic regions, including Europe and Latin America, by 2025. The capital raised from the IPO will be utilized to support these growth initiatives.

## Funding rounds

- Series B, Sep 30, 2013, $100M — TPG, The Advisory Board Company, UPMC Health Plan, Inc.

## Investors

- TPG (https://capitalatlas.ai/funds/tpg) — Series B
- The Advisory Board Company — Series B
- UPMC Health Plan, Inc. — Series B